Cytotoxic T Lymphocyte-Associated Molecule-4 Polymorphism and Relapse of Graves’ Hyperthyroidism after Antithyroid Withdrawal-Reference-Cited by-同舟云学术

Cytotoxic T Lymphocyte-Associated Molecule-4 Polymorphism and Relapse of Graves’ Hyperthyroidism after Antithyroid Withdrawal

Published:2004-01-01 Issue:1 Volume:89 Page:169-173
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Wang Pei-Wen¹,Liu Rue-Tsuan¹,Juo Suh-Hang Hank²,Wang Shan-Tair³,Hu Ya-Hui¹,Hsieh Ching-Jung¹,Chen Ming-Hong¹,Chen I-Ya¹,Wu Chia-Ling¹

Affiliation:

1. Department of Internal Medicine (P.-W.W., R.-T.L., Y.-H.H., C.-J.H., M.-H.C., I.-Y.C., C.-L.W.), Chang Gung Memorial Hospital, Kaohsiung 83305, Taiwan

2. Columbia Genome Center and Department of Epidemiology (S.-H.H.J.), Columbia University, New York, NY 10032

3. Department of Public Health (S.-T.W.), National Cheng Kung University Medical Center, Tainan 70101, Taiwan

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/89/1/169/10741968/jcem0169.pdf

Reference39 articles.

1. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves’ disease.;Takamatsu;Ann Intern Med,1984

2. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease.;Cooper;Endocrinol Metab Clin North Am,1998

3. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves’ disease.;Schleusener;Acta Endocrinol,1989

4. Clinical features of patients with Graves’ disease undergoing remission after antithyroid drug treatment.;Vitti;Thyroid,1997

5. Outcome of Graves’ disease after antithyroid drug treatment in Taiwan.;Wang;J Formos Med Assoc,1998

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between CTLA-4 +49A/G (rs231775) polymorphism and the risk of autoimmune thyroid diseases: A systematic review and meta-analysis;2023-12-15

2. Research Progress on Influencing Factors of Graves’ Disease Recurrence Treated with Antithyroid Drugs;Advances in Clinical Medicine;2023

3. Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review;International Journal of Endocrinology and Metabolism;2020-06-29

4. A significant association of the CTLA4 gene variants with the risk of autoimmune Graves’ disease in ethnic Kashmiri population;Cellular Immunology;2020-01

5. Long-term remission following antithyroid drug withdrawal in patients with Graves’ hyperthyroidism: parameters with prognostic value;Endocrine;2018-10-17